Altimmune to Present at the H.C. Wainwright 23rd Annual Global Investment Conference September 13-15, 2021
Get Alerts ALT Hot Sheet
Join SI Premium – FREE
GAITHERSBURG, Md., Sept. 07, 2021 (GLOBE NEWSWIRE) -- Altimmune, Inc. (Nasdaq: ALT), a clinical-stage biopharmaceutical company, today announced that members of the management team will present during a fireside chat at the H.C. Wainwright 23rd Annual Global Investment Conference, being held virtually on September 13-15, 2021.
Details on the H.C. Wainwright fireside chat presentation are as follows:
Title: | H.C. Wainwright 23rd Annual Global Investment Conference | |||
Presenters: | Vipin Garg, Ph.D., Chief Executive Officer | |||
Scott Harris, M.D., Chief Medical Officer | ||||
Date/Time: | Monday, September 13, 2021 (virtual pre-record available at 7 a.m. EST) |
A webcast link to the fireside chat presentation will be accessible on the Events section of the Altimmune website.
About Altimmune
Altimmune is a clinical stage biopharmaceutical company focused on developing treatments for obesity and liver diseases. Our pipeline includes next generation peptide therapeutics for obesity, NASH (ALT-801), and chronic hepatitis B (HepTcell™). For more information, please visit www.altimmune.com.
Follow @Altimmune, Inc. on LinkedInFollow @AltimmuneInc on Twitter
Investor & Media Contacts:
Will Brown Chief Financial Officer Phone: 240-654-1450 [email protected]
Source: Altimmune, Inc
Serious News for Serious Traders! Try StreetInsider.com Premium Free!
You May Also Be Interested In
- Meritage Homes reports first quarter 2024 results
- Mark Hutchinson Joins F&M Bank as Treasurer
- The Cigna Group Declares Quarterly Dividend
Create E-mail Alert Related Categories
Globe Newswire, Press ReleasesRelated Entities
Twitter, H.C. WainwrightSign up for StreetInsider Free!
Receive full access to all new and archived articles, unlimited portfolio tracking, e-mail alerts, custom newswires and RSS feeds - and more!